Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency

H Hassoun, JN Vassiliadis, J Murray, PR Njolstad, JJ Rogus, SK Ballas, F Schaffer, P Jarolim, V Brabec, J Palek

. 1997 ; 90 (1) : 398-406.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc14061857

Grantová podpora
IZ4118 MZ0 CEP - Centrální evidence projektů

Several subsets of patients with hereditary spherocytosis (HS) have been defined based on the specific red blood cell membrane protein deficiencies involving spectrin, ankyrin, band 3, and protein 4.2. Mutations of the genes encoding these proteins are currently being uncovered. Regarding spectrin, only three isolated cases of beta-spectrin gene mutations were recently reported in association with HS and spectrin deficiency. We have screened the coding region of the beta-spectrin gene using the SSCP technique, in 40 families with HS associated with spectrin deficiency or combined spectrin and ankyrin deficiencies. In this report we describe six frameshift and nonsense mutations and four missense mutations of the beta-spectrin gene in 11 unrelated families. Taking advantage of modifications in the restriction enzyme recognition sequences introduced by the mutations, we show, in all cases of frameshift and nonsense mutations, the loss of heterozygosity at the cDNA level when compared to genomic DNA, reflecting the absence of the mutant mRNA transcripts. In one family with a large pedigree including six generations and 112 members, we firmly establish the autosomal dominant inheritance of one of the beta-spectrin null mutations. Most of the mutations described are responsible for a phenotype of mild to moderate autosomal dominant form of HS associated with a conspicuous spherocytosis with frequent spiculated cells (8% to 15% acanthocytes). One missense mutation appears to be associated with a recessive form of the disease. Five common restriction enzyme polymorphisms of the coding region of the beta-spectrin gene are also described. Overall, these findings underscore the importance of the beta-spectrin gene mutations in the pathogenesis of HS and reemphasizes the extreme heterogeneity of the underlying molecular basis of this condition.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14061857
003      
CZ-PrNML
005      
20140627140034.0
007      
ta
008      
140617s1997 xxua f 000 0|eng||
009      
AR
035    __
$a (PubMed)9207476
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hassoun, H. $u Department of Biomedical Research, St Elizabeth's Medical Center of Boston, Tufts University Medical School, MA 02135, USA
245    10
$a Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency / $c H Hassoun, JN Vassiliadis, J Murray, PR Njolstad, JJ Rogus, SK Ballas, F Schaffer, P Jarolim, V Brabec, J Palek
504    __
$a Literatura
520    9_
$a Several subsets of patients with hereditary spherocytosis (HS) have been defined based on the specific red blood cell membrane protein deficiencies involving spectrin, ankyrin, band 3, and protein 4.2. Mutations of the genes encoding these proteins are currently being uncovered. Regarding spectrin, only three isolated cases of beta-spectrin gene mutations were recently reported in association with HS and spectrin deficiency. We have screened the coding region of the beta-spectrin gene using the SSCP technique, in 40 families with HS associated with spectrin deficiency or combined spectrin and ankyrin deficiencies. In this report we describe six frameshift and nonsense mutations and four missense mutations of the beta-spectrin gene in 11 unrelated families. Taking advantage of modifications in the restriction enzyme recognition sequences introduced by the mutations, we show, in all cases of frameshift and nonsense mutations, the loss of heterozygosity at the cDNA level when compared to genomic DNA, reflecting the absence of the mutant mRNA transcripts. In one family with a large pedigree including six generations and 112 members, we firmly establish the autosomal dominant inheritance of one of the beta-spectrin null mutations. Most of the mutations described are responsible for a phenotype of mild to moderate autosomal dominant form of HS associated with a conspicuous spherocytosis with frequent spiculated cells (8% to 15% acanthocytes). One missense mutation appears to be associated with a recessive form of the disease. Five common restriction enzyme polymorphisms of the coding region of the beta-spectrin gene are also described. Overall, these findings underscore the importance of the beta-spectrin gene mutations in the pathogenesis of HS and reemphasizes the extreme heterogeneity of the underlying molecular basis of this condition.
536    __
$c Grant Number: HL27215 (United States NHLBI NIH HHS)
536    __
$c Grant Number: HL37462 (United States NHLBI NIH HHS)
536    __
$c Grant Number: K08 HL02720 (United States NHLBI NIH HHS)
590    __
$a bohemika - dle Pubmed
650    02
$a komplementární DNA $x genetika $7 D018076
650    02
$a ženské pohlaví $7 D005260
650    02
$a posunová mutace $7 D016368
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a rodokmen $7 D010375
650    02
$a spektrin $x genetika $x nedostatek $7 D013049
650    12
$a dědičná sférocytóza $x genetika $x metabolismus $7 D013103
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, P.H.S. $7 D013487
700    1_
$a Vassiliadis, J. N. $u Department of Pediatrics and Medical Genetics, Haukeland University Hospital, Bergen, Norway
700    1_
$a Murray, J. $u Harvard School of Public Health, Program for Population Genetics, Cambridge, MA
700    1_
$a Njolstad, P. R. $u Department of Medicine, Cardeza Foundation for Hematologie Research, Jefferson Medical College, Philadelphia, PA
700    1_
$a Rogus, J. J. $u Department of Pediatrics at Temple University School of Medicine, St Christopher's Hospital for Children, Philadelphia, PA
700    1_
$a Ballas, S. K.
700    1_
$a Schaffer F.
700    1_
$a Jarolím, Petr, $d 1955- $7 jn20000710077 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Brabec, Václav, $d 1925- $7 xx0073920 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Palek J $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
773    0_
$t Blood $x 0006-4971 $g Roč. 90, č. 1 (1997), s. 398-406 $p Blood $w MED00000807
773    0_
$p Blood $g 90(1):398-406, 1997 Jul 1 $x 0006-4971
910    __
$a ABA008 $b B 405 $c 315 $y 4 $z 0
990    __
$a 20140617162339 $b ABA008
991    __
$a 20140627140308 $b ABA008
999    __
$a ok $b bmc $g 1029227 $s 860517
BAS    __
$a 3
BMC    __
$a 1997 $b 90 $c 1 $d 398-406 $x MED00000807 $i 0006-4971 $m Blood $n Blood
GRA    __
$a IZ4118 $p MZ0
LZP    __
$a 2014-06/gvbo

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...